Aerpio Pharmaceuticals, Inc.
ARPO · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$63,691 | -$36,917 | -$23,155 | -$22,181 |
| Dep. & Amort. | -$1,108 | $892 | $1,169 | $1,114 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $10,839 | $3,105 | $2,882 | $3,475 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | -$5,590 | $439 | -$4,471 | -$678 |
| Operating Cash Flow | -$59,550 | -$32,481 | -$23,575 | -$18,270 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,654 | -$2,211 | -$1,304 | -$824 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$36,482 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $63,338 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $25,202 | -$2,211 | -$1,304 | -$824 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $130 | $44,016 | $25,518 | $23,210 |
| Financing Cash Flow | $130 | $44,016 | $25,518 | $23,210 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$34,218 | $9,324 | $639 | $4,116 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $62,952 | $11,488 | $10,849 | $6,733 |
| End Cash | $28,734 | $20,812 | $11,488 | $10,849 |
| Free Cash Flow | -$61,204 | -$34,692 | -$24,879 | -$19,094 |